USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12312
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuza, Anastasia
dc.contributor.authorParii, Sergiu
dc.contributor.authorButovscaia, Cristina
dc.contributor.authorGalea-Abdusa, Daniela
dc.contributor.authorRadulescu, Luminita
dc.contributor.authorCurocichin, Ghenadie
dc.date.accessioned2020-10-26T13:07:10Z
dc.date.available2020-10-26T13:07:10Z
dc.date.issued2020
dc.identifier.citationBUZA, Anastasia, PARII, Sergiu, BUTOVSCAIA, Cristina, et al. Prevalence of 35delG mutation in GJB2 gene in the Moldovan population. In: The Moldovan Medical Journal. 2020, vol. 63, no 6, pp. 33-35. ISSN 2537-6381. DOI: 10.5281/zenodo.4028375en_US
dc.identifier.issn2537-6381
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2020/10/63-6-00-Spaltul-3-din-06-10-20-final.pdf
dc.identifier.urihttps://doi.org/10.5281/zenodo.4028375
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12312
dc.descriptionLaboratory of Genetics, Center for Drug Research, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania. The 75th anniversary of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova (1945-2020)en_US
dc.description.abstractBackground: Guanine deletion 35delG in GJB2 exon 2 is the pathogenic mutation responsible for up to 70% of cases of congenital non-syndromic sensorineural hearing loss (NSHL) among Europeans. The early molecular diagnostic of hearing loss nature has become important while considering the cochlear implants. The purpose of this study was to establish the frequency of 35delG deletion in GJB2 gene among patients with severe NSHL and its prevalence among Moldovan residents with normal hearing. Material and methods: 40 patients with congenital bilateral profound NSHL and 300 individuals with normal hearing were examined for deletion 35delG, by using Custom TaqMan SNP genotyping Assay. Results: 12 (30%) patients with homozygous genotype for 35delG mutation were identified, whereas 8 patients (20%) were heterozygous. The study reported 4 (1.33%) carriers of 35delG mutation among 300 Moldovan individuals with normal hearing. Conclusions: The present study results suggest a need for including the 35delG molecular testing into the national program of neonatal screening of hearing loss. Considerations on the genetic carrier testing should be made in genetic counseling and family planning.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldova
dc.relation.ispartofThe Moldovan Medical Journal: The 75th anniversary of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova (1945-2020)
dc.subjectGJB2en_US
dc.subject35delG mutationen_US
dc.subjectnon-syndromic deafnessen_US
dc.subject.ddcUDC: 575.224.22:616.28-008.14(478)en_US
dc.titlePrevalence of 35delG mutation in GJB2 gene in the Moldovan populationen_US
dc.typeArticleen_US
Appears in Collections:The Moldovan Medical Journal, Vol. 63, No 6, December 2020



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback